We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ALGS icon
826
Aligos Therapeutics
ALGS
$29.4M
$29.4M $4.75 3.26%
BCTX
827
Briacell Therapeutics
BCTX
$29.3M
$29.3M $3.37 0.3%
CCEL icon
828
Cryo-Cell International
CCEL
$28.7M
$28.7M $3.56 2.3%
HBIO icon
829
Harvard Bioscience
HBIO
$28.5M
$28.5M $6.31 0%
MIRA icon
830
MIRA Pharmaceuticals
MIRA
$28.4M
$28.4M $0.6750 9.95%
KYNB
831
Kyntra Bio
KYNB
$28M
$28M $6.92 2.37%
ABVC icon
832
ABVC BioPharma
ABVC
$27.8M
$27.8M $1.07 2.88%
EYEG icon
833
AB Corporate Bond ETF
EYEG
$27.8M
$27.8M $34.70 0.49%
BEAT icon
834
Heartbeam
BEAT
$27.6M
$27.6M $0.4966 0.98%
OPTH
835
Optimi Health Corp
OPTH
$26.8M
$26.8M $4.77 1.65%
QNCX icon
836
Quince Therapeutics
QNCX
$26.8M
$26.8M $27.41 9.77%
ACTU
837
Actuate Therapeutics
ACTU
$26.8M
$26.8M $1.12 5.66%
BTAI icon
838
BioXcel Therapeutics
BTAI
$26.6M
$26.6M $0.8606 1.53%
CRVO icon
839
CervoMed
CRVO
$25.9M
$25.9M $2.80 7.69%
IGC icon
840
IGC Pharma
IGC
$25.9M
$25.9M $0.2480 1.18%
ATNM icon
841
Actinium Pharmaceuticals
ATNM
$25.4M
$25.4M $0.8100 0.18%
YARW
842
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
$25.3M $37.95 13%
EVAX
843
Evaxion A/S
EVAX
$24.6M
$24.6M $2.95 5.73%
CVM icon
844
CEL-SCI Corp
CVM
$23.8M
$23.8M $1.36 8.8%
AYTU icon
845
AYTU BioPharma
AYTU
$23.7M
$23.7M $2.21 1.78%
CTSO icon
846
Cytosorbents Corp
CTSO
$23.7M
$23.7M $0.3774 2.53%
TXMD icon
847
TherapeuticsMD
TXMD
$23.6M
$23.6M $2.04 0%
NXTC icon
848
NextCure
NXTC
$23.5M
$23.5M $5.78 31.4%
LGVN
849
Longeveron
LGVN
$23.4M
$23.4M $0.7421 1.38%
BRNS
850
Barinthus Biotherapeutics
BRNS
$23.1M
$23.1M $0.5647 5.87%

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.